Tag Archives: Data

Lanham Act: Peer-Review on Trial

Scientific opinion has special protection under the First Amendment, but does that give pharma a free pass to BYOD – build your own dataset – publish a peer-reviewed article based on the data, and then promote it for competitive advantage? The dividing line between fact and fiction becomes increasingly blurry in the age of prolific […]
Posted in Advertising, compliance, Legal, Marketing, Regulatory, Strategy | Also tagged , , , , , , , , | Leave a comment

Pharma in the Dell: Working with Academia

How can the emerging field of data science help to fruitfully translate research and discovery into successful drug development? Academics and pharmaceutical executives at Mount Sinai’s School of Medicine discussed ways to build a bridge across the valley of death, and the growing importance of data across all business areas.
Posted in Biotech, Deals, IP, leadership, Meetings, People, R&D, Strategy, Technology | Also tagged , , , , , | Leave a comment

Missed Opportunities in Advanced Data Analytics

SAS’s Brad Sitler talks about the importance of incremental sales, customer proximity, and anticipating a compensation model based on health outcomes
Posted in Advertising, healthcare, leadership, Marketing | Also tagged , , | Leave a comment

Unbranded Pharma Sites Gain Traction

Image by alles-schlumpf via Flickr The popularity of unbranded pharma Web sites amongst consumers appears to be on an up tick, according to new data released by Manhattan Research this week. The report, “Unbranded Web sites: Brand Reach throughout the Patient Life Cycle” looked at how many consumers actively use unbranded pharma sites and to […]
Posted in Marketing | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta